Facio partners with Evotec and initiates FSHD drug discovery programme
30-Apr-2015 -
Evotec AG and Facio Therapies announced that they have entered into an agreement aimed at the identification of compounds showing activity as a potential treatment to stop the progression of FSHD (Facioscapulohumeral dystrophy), a muscle wasting disease. This agreement marks the start of finding ...
cell lines
drug discovery
muscles